No registrations found.
ID
NL-OMON20289
Source
Nationaal Trial Register
Brief title
CEMASIS
Health condition
Atrial Fibrillation, Ischemic Stroke
Sponsors and support
Primary sponsor
:
Medisch Spectrum Twente
Source(s) of monetary or material Support
:
Medisch Spectrum Twente
Intervention
Outcome measures
Primary outcome
The incidence of atrial fibrillation in the acute setting of ischemic stroke.
Secondary outcome
1. The incidence of atrial fibrillation in increased body-mass-index;
2. The incidence of atrial fibrillation in symptomatic patients;
3. The incidence of accelerated atrial activity < 30 seconds.
Background summary
N/A
Study objective
24-hours cardiac event monitoring is useful in the acute inpatient setting of ischemic stroke.
Study design
24 hours.
Intervention
24 hours event monitoring in ischemic stroke patients.
Public
Scientific
Inclusion criteria
Patients with current ischemic stroke.
Exclusion criteria
Prior documented paroxysmal, persistent or chronic atrial fibrillation.
Design
Study type
:
Observational non invasive
Intervention model
:
Parallel
Allocation
:
Non controlled trial
Masking
:
Open (masking not used)
Control
:
N/A , unknown
Recruitment
NL
Recruitment status
:
Recruiting
Start date (anticipated)
:
Enrollment
:
150
Type
:
Anticipated
Not applicable
Application type
:
Not applicable
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL2845 |
| NTR-old | NTR2987 |
| Other | : CEMSIS-1 |
Summary results
N/A